Chemoport-A Savior in Children Who Require Chronic Venous Access: An Observational Study

Veerabhadra Radhakrishna1, Chittur Narendra Radhakrishnan2, Ravikiran Cheelenahalli Srinivasa Rao2

  • 1Department of Paediatric Surgery, Bangalore Medical College and Research Institute, Bengaluru, India.

Insights

Chemoports provide safe and reliable long-term venous access for children needing chronic treatment. This study confirms chemoports have a low complication rate, making them ideal for pediatric patients requiring venous access.

Area of Science:

  • Pediatric Surgery
  • Vascular Access Devices
  • Oncology

Background:

  • Pediatric long-term venous access presents challenges due to small vein size and patient cooperation.
  • Chronic venous access is crucial for administering treatments to children with serious illnesses.

Purpose of the Study:

  • To evaluate the indications, efficacy, and safety of chemoport insertion in children requiring chronic venous access.
  • To assess the complication rates and outcomes associated with chemoports in a pediatric population.

Main Methods:

  • Retrospective evaluation of children who underwent chemoport insertion between January 2008 and December 2017.
  • Analysis of indications for insertion, duration of use, and complication events.

Main Results:

  • 169 chemoports were inserted in 159 children; acute lymphoblastic leukemia was the most common indication (51.5%).
  • Mean duration of chemoport use was 832±666 days, with 55.0% removed post-treatment.
  • The overall complication rate was 0.15 per 1,000 chemoport days, with port-related bloodstream infection being the most frequent (0.09 per 1,000 chemoport days).

Conclusions:

  • Chemoports are a safe and reliable option for long-term venous access in children.
  • The low complication rate supports the use of chemoports for managing pediatric patients with chronic venous access needs.
  • Effective management with chemoports can improve outcomes for children with life-threatening conditions.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
668
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
153
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
184
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
121